Deep Learning-Based Virtual Screening Identifies Potential Small-Molecule Inhibitors of ASK1: Natural Product Lead Discovery for MASH
International Journal of Molecular Sciences · 20.07.2026 · 27 (14) · 6438
DOI: 10.3390/ijms27146438 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.07.2026. Verfasst von Ruiqi Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518033, China. Hauptthemen laut MEDLINE: MAP Kinase Kinase Kinase 5, Biological Products, Deep Learning, Drug Discovery. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, The Natural Science Foundation of China, Natural Science Foundation of China.
Abstract (Originalsprache)
Apoptosis signal-regulating kinase 1 (ASK1) represents a critical therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH). Natural products, owing to their unique chemical diversity, constitute a rich reservoir for discovering novel ASK1 inhibitors. The emergence of artificial intelligence-assisted drug discovery (AIDD) has opened new avenues for exploring small-molecule inhibitors. Through virtual screening, molecular docking, interaction profiling, molecular dynamics simulations, and MM-GBSA binding free energy calculations, we systematically evaluated the binding mode, stability, and key residue contributions of the CMNPD10921–ASK1 complex. CMNPD10921 stably occupied the ASK1 active pocket, forming hydrophobic interactions and hydrogen bonds with multiple key amino acid residues. MM-GBSA analysis yielded a total computed binding free energy of −31.15 kcal/mol, suggesting a computationally favorable interaction, with van der Waals forces serving as the dominant energetic driver of complex stabilization. Residue energy decomposition further identified ILE324, THR288, and THR639 as major contributors to ligand binding. Integrating deep learning, molecular simulation, and quantum chemical calculations, this study successfully identified CMNPD10921 from a vast natural product library as a putative lead compound candidate targeting the ASK1 central regulatory region, offering a novel candidate molecule for anti-MASH drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518033, China.
- The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
- Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao 999078, China.
ORCID-Profile: Xiaozhou Zhou
Förderung
- Shenzhen Science and Technology Program
- The Natural Science Foundation of China
- Natural Science Foundation of China
Zitieren
APA
Zhao, R., Yang, J., Han, M., Tang, S., Hu, H., Guo, J., Ma, M., Sun, J., & Zhou, X. (2026). Deep Learning-Based Virtual Screening Identifies Potential Small-Molecule Inhibitors of ASK1: Natural Product Lead Discovery for MASH. International Journal of Molecular Sciences, 27(14), 6438. https://doi.org/10.3390/ijms27146438
Vancouver
Zhao R, Yang J, Han M, Tang S, Hu H, Guo J, et al. Deep Learning-Based Virtual Screening Identifies Potential Small-Molecule Inhibitors of ASK1: Natural Product Lead Discovery for MASH. International Journal of Molecular Sciences. 2026;27(14):6438. doi:10.3390/ijms27146438
BibTeX
@article{Zhao2026,
author = {Zhao, Ruiqi and Yang, Jiahua and Han, Mengyao and Tang, Shiqi and Hu, Hui and Guo, Jiesheng and Ma, Mengqing and Sun, Jialing and Zhou, Xiaozhou},
title = {Deep Learning-Based Virtual Screening Identifies Potential Small-Molecule Inhibitors of ASK1: Natural Product Lead Discovery for MASH},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6438},
doi = {10.3390/ijms27146438}
}
EUVIMED